AmirAli Talasaz's most recent trade in Guardant Health Inc was a trade of 23,997 Restricted Stock Units done . Disclosure was reported to the exchange on June 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 23,997 | 47,995 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 23,997 | 1,906,722 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.77 per share. | 30 Jun 2026 | 17,086 | 1,899,351 (2%) | 0% | 170.8 | 2,917,776 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 9,715 | 1,916,437 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 9,715 | 58,296 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 2,817 | 1,884,153 (1%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 2,817 | 5,634 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 150.03 per share. | 30 Jun 2026 | 1,428 | 1,882,725 (1%) | 0% | 150.0 | 214,243 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2026 | 143,028 | 28,997 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 26 Jun 2026 | 143,028 | 2,024,364 (2%) | 0% | 4.2 | 597,857 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2026 | 111,804 | 172,025 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 26 Jun 2026 | 111,804 | 1,998,308 (2%) | 0% | 4.2 | 467,341 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 151.47 per share. | 26 Jun 2026 | 70,513 | 1,928,039 (2%) | 0% | 151.5 | 10,680,315 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 150.49 per share. | 26 Jun 2026 | 64,037 | 1,934,271 (2%) | 0% | 150.5 | 9,636,838 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 151.16 per share. | 26 Jun 2026 | 52,935 | 1,881,336 (1%) | 0% | 151.2 | 8,001,628 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 152.20 per share. | 26 Jun 2026 | 46,663 | 1,881,376 (1%) | 0% | 152.2 | 7,102,319 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 150.53 per share. | 26 Jun 2026 | 25,812 | 1,998,552 (2%) | 0% | 150.5 | 3,885,434 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 153.00 per share. | 26 Jun 2026 | 40 | 1,881,336 (1%) | 0% | 153 | 6,120 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 112.02 per share. | 20 May 2026 | 37,900 | 1,912,856 (2%) | 0% | 112.0 | 4,245,547 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 111.14 per share. | 20 May 2026 | 37,163 | 1,950,756 (2%) | 0% | 111.1 | 4,130,470 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 108.11 per share. | 20 May 2026 | 33,069 | 2,026,679 (2%) | 0% | 108.1 | 3,574,961 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 110.10 per share. | 20 May 2026 | 28,908 | 1,987,919 (2%) | 0% | 110.1 | 3,182,652 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 112.76 per share. | 20 May 2026 | 26,352 | 1,886,504 (1%) | 0% | 112.8 | 2,971,430 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 106.99 per share. | 20 May 2026 | 21,171 | 2,059,748 (2%) | 0% | 107.0 | 2,265,126 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 105.01 per share. | 20 May 2026 | 11,919 | 2,082,119 (2%) | 0% | 105.0 | 1,251,589 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 108.97 per share. | 20 May 2026 | 9,852 | 2,016,827 (2%) | 0% | 109.0 | 1,073,547 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 103.82 per share. | 20 May 2026 | 1,366 | 2,094,038 (2%) | 0% | 103.8 | 141,815 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 105.88 per share. | 20 May 2026 | 1,200 | 2,080,919 (2%) | 0% | 105.9 | 127,050 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.57 per share. | 20 May 2026 | 900 | 2,095,404 (2%) | 0% | 102.6 | 92,313 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.95 per share. | 20 May 2026 | 200 | 2,096,304 (2%) | 0% | 101.0 | 20,190 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.32 per share. | 12 May 2026 | 50,000 | 2,096,504 (2%) | 0% | 100.3 | 5,016,000 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 23,997 | 2,153,875 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 23,997 | 71,992 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.15 per share. | 31 Mar 2026 | 17,087 | 2,146,504 (2%) | 0% | 91.1 | 1,557,480 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 9,716 | 68,011 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 9,716 | 2,163,591 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 2,817 | 8,451 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 2,817 | 2,131,306 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.37 per share. | 31 Mar 2026 | 1,428 | 2,129,878 (2%) | 0% | 92.4 | 131,904 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 101,409 | 101,409 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 38,283 | 2,134,594 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 38,283 | 77,727 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 26,961 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 26,961 | 2,142,153 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.14 per share. | 01 Jan 2026 | 19,402 | 2,115,192 (2%) | 0% | 102.1 | 1,981,720 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.49 per share. | 01 Jan 2026 | 13,664 | 2,128,489 (2%) | 0% | 85.5 | 1,168,135 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 01 Jan 2026 | 13,209 | 0 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 01 Jan 2026 | 13,209 | 2,096,311 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 11,268 | 11,268 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,000,248 | 2,000,248 (2%) | 2% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,000,248 | 13,209 (0%) | 2% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 82,854 | 2,083,102 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 82,854 | 0 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 23,997 | 2,024,245 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 23,997 | 95,989 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.14 per share. | 31 Dec 2025 | 10,788 | 2,013,457 (2%) | 0% | 102.1 | 1,101,886 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 4,815 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 4,815 | 2,002,689 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.14 per share. | 31 Dec 2025 | 2,441 | 2,000,248 (2%) | 0% | 102.1 | 249,324 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2025 | 387,946 | 82,854 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2025 | 193,973 | 218,223 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2025 | 193,973 | 218,223 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 105.34 per share. | 08 Dec 2025 | 30,760 | 172,463 (0%) | 0% | 105.3 | 3,240,172 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 105.34 per share. | 08 Dec 2025 | 30,760 | 172,463 (0%) | 0% | 105.3 | 3,240,172 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 104.21 per share. | 08 Dec 2025 | 15,000 | 203,223 (0%) | 0% | 104.2 | 1,563,125 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 104.21 per share. | 08 Dec 2025 | 15,000 | 203,223 (0%) | 0% | 104.2 | 1,563,125 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 106.00 per share. | 08 Dec 2025 | 4,240 | 168,223 (0%) | 0% | 106 | 449,440 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 106.00 per share. | 08 Dec 2025 | 4,240 | 168,223 (0%) | 0% | 106 | 449,440 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 23,997 | 2,010,036 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 23,997 | 119,986 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.65 per share. | 30 Sep 2025 | 12,162 | 1,997,874 (2%) | 0% | 62.6 | 761,949 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 4,814 | 4,815 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Talasaz AmirAli | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 4,814 | 1,988,479 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Talasaz AmirAli | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.48 per share. | 30 Sep 2025 | 2,440 | 1,986,039 (2%) | 0% | 62.5 | 152,451 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.67 per share. | 30 Jun 2025 | 72,068 | 1,999,762 (2%) | 0% | 50.7 | 3,651,794 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.40 per share. | 30 Jun 2025 | 27,932 | 1,971,830 (2%) | 0% | 51.4 | 1,435,836 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 23,997 | 143,983 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 23,997 | 1,995,827 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.71 per share. | 30 Jun 2025 | 12,162 | 1,983,665 (2%) | 0% | 50.7 | 616,735 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 4,815 | 9,629 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 4,815 | 2,074,271 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.04 per share. | 30 Jun 2025 | 2,441 | 2,071,830 (2%) | 0% | 52.0 | 127,030 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.09 per share. | 05 Jun 2025 | 77,853 | 2,069,456 (2%) | 0% | 50.1 | 3,899,937 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.07 per share. | 05 Jun 2025 | 39,751 | 2,147,309 (2%) | 0% | 50.1 | 1,990,420 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 05 Jun 2025 | 1,680 | 2,187,060 (2%) | 0% | 50.0 | 84,007 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.53 per share. | 01 May 2025 | 44,691 | 2,208,219 (2%) | 0% | 49.5 | 2,213,711 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.71 per share. | 01 May 2025 | 38,477 | 2,252,910 (2%) | 0% | 48.7 | 1,874,299 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 47.67 per share. | 01 May 2025 | 18,069 | 2,291,387 (2%) | 0% | 47.7 | 861,275 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.47 per share. | 01 May 2025 | 13,932 | 2,188,740 (2%) | 0% | 50.5 | 703,151 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.91 per share. | 01 May 2025 | 3,445 | 2,204,774 (2%) | 0% | 50.9 | 175,395 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.56 per share. | 01 May 2025 | 1,748 | 2,203,026 (2%) | 0% | 51.6 | 90,131 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 52.57 per share. | 01 May 2025 | 354 | 2,202,672 (2%) | 0% | 52.6 | 18,611 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 23,998 | 167,980 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 23,998 | 2,321,619 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 31 Mar 2025 | 12,163 | 2,309,456 (2%) | 0% | 42.5 | 516,563 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,814 | 2,300,061 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,814 | 14,444 | - | - | Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.60 per share. | 31 Mar 2025 | 2,440 | 2,297,621 (2%) | 0% | 42.6 | 103,944 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 68,769 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 68,769 | 2,330,100 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.89 per share. | 14 Mar 2025 | 34,853 | 2,295,247 (2%) | 0% | 42.9 | 1,494,845 | Common Stock |